2020-12-28,"Arvinas, Inc. Announces Exercise of Underwriters Option to Purchase Additional Shares"
2020-12-23,3 Strong Buy Stocks Insiders Are Snapping Up
2020-12-16,"Biotech Stock Roundup: ALXN Up on Acquisition News, PFE-BNTX Get EUA for Vaccine & More"
2020-12-15,"Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock"
2020-12-15,"Arvinas Cancer Drug Has Blockbuster Potential, Says Analyst"
2020-12-15,ROCE Insights For Arvinas
2020-12-15,Arvinas (ARVN) Up on Promising Interim Data on Cancer Candidates
2020-12-14,Why This Small Biotech Stock Nearly Doubled In Bullish Volume
2020-12-14,"Arvinas, Inc. Announces Proposed Offering of Common Stock"
2020-12-14,Arvinas Nearly Doubles on Promising Cancer Drug Results
2020-12-14,Return On Capital Employed Overview: Arvinas
2020-12-14,Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110
2020-12-11,Arvinas to Host Webcast Presentation of New Clinical Data from ARV-471 and ARV-110 PROTAC® Protein Degrader Development Programs
2020-11-25,Arvinas to Participate in Upcoming Virtual Investor Conferences
2020-11-16,New Strong Sell Stocks for November 16th
2020-11-07,"Arvinas, Inc. (NASDAQ:ARVN) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year"
2020-11-05,Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
2020-11-05,Rock star Growth Puts Arvinas (NASDAQ:ARVN) In A Position To Use Debt
2020-10-14,Arvinas Announces Pipeline Programs Targeting Validated and Classically Undruggable Disease-Causing Proteins
2020-10-06,Arvinas to Present at the 3rd Annual Targeted Protein Degradation Summit
2020-09-15,"Hedge Funds Have Never Been This Bullish On Arvinas, Inc. (ARVN)"
2020-09-04,Arvinas to Present at the Citi 15th Annual BioPharma Virtual Conference
2020-08-07,Arvinas to Present at the 2020 Wedbush PacGrow Virtual Healthcare Conference
2020-08-04,"Arvinas, Inc. (ARVN) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-04,Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update
2020-07-30,The Arvinas (NASDAQ:ARVN) Share Price Has Gained 30% And Shareholders Are Hoping For More
2020-07-27,"Earnings Preview: Arvinas, Inc. (ARVN) Q2 Earnings Expected to Decline"
2020-07-20,"Did Hedge Funds Make The Right Call On Arvinas, Inc. (ARVN) ?"
2020-06-29,"Arvinas Appoints Wendy Dixon, Ph.D., to its Board of Directors"
2020-06-17,Arvinas to Present Virtually at the BMO 2020 Prescriptions for Success Healthcare Conference
2020-06-15,"Here is What Hedge Funds Think About Arvinas, Inc. (ARVN)"
2020-06-11,Arvinas Appoints Linda Bain to its Board of Directors
2020-06-05,"Arvinas, Inc. (ARVN) Upgraded to Buy: Here's Why"
2020-06-05,Arvinas to Present Virtually at the Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-29,P/E Ratio Insights for Arvinas
2020-05-29,Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader ARV-110 in Patients with Metastatic Castration-Resistant Prostate Cancer
2020-05-20,Arvinas to Hold Virtual 2020 Annual Meeting of Stockholders
2020-05-14,Here's Why Arvinas Shares Are Tumbling 13.7% Today
2020-05-13,Arvinas Announces Updated Phase 1 Data Demonstrating Clinical Activity of PROTAC® Protein Degrader ARV-110 in Patients with Refractory Prostate Cancer
2020-05-12,How Arvinas (ARVN) Stock Stands Out in a Strong Industry
2020-05-05,"Arvinas, Inc. (ARVN) Upgraded to Buy: Here's What You Should Know"
2020-05-01,"Analysts Are Upgrading Arvinas, Inc. (NASDAQ:ARVN) After Its Latest Results"
2020-04-28,Recap: Arvinas Q1 Earnings
2020-04-28,"Arvinas, Inc. (ARVN) Reports Q1 Loss, Tops Revenue Estimates"
2020-04-28,Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
2020-04-18,"Were Hedge Funds Right About Arvinas, Inc. (ARVN)?"
2020-04-13,Arvinas Provides Update on Business Continuity Related to the Impact of the COVID-19 Pandemic
2020-03-31,Arvinas to Present at the American Society of Clinical Oncology Annual Meeting
2020-03-31,"The Arvinas, Inc. (NASDAQ:ARVN) Analysts Have Been Trimming Their Sales Forecasts"
2020-03-20,Is Arvinas (ARVN) Outperforming Other Medical Stocks This Year?
2020-03-19,Why You Shouldn't Bet Against Arvinas (ARVN) Stock
2020-03-18,Is Arvinas (NASDAQ:ARVN) A Risky Investment?
2020-03-16,"Arvinas, Inc. (ARVN) Reports Q4 Loss, Tops Revenue Estimates"
2020-03-16,Arvinas Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
2020-02-17,"Arvinas, Inc. (ARVN) Upgraded to Buy: What Does It Mean for the Stock?"
2020-01-31,What's in the Offing for Emerson (EMR) in Q1 Earnings?
2020-01-29,Will Arvinas Continue to Surge Higher?
2020-01-17,Shareholders Are Thrilled That The Arvinas (NASDAQ:ARVN) Share Price Increased 208%
2019-12-19,"Did Hedge Funds Drop The Ball On Arvinas, Inc. (NASDAQ:ARVN) ?"
2019-11-27,Arvinas to Present at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-26,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug"
2019-11-25,"Arvinas TPD Therapies Have Great Potential, Guggenheim Says In Bullish Initiation"
2019-11-21,"Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors"
2019-11-17,"Notable Insider Buys In The Past Week: Arvinas, Dropbox, Trinity"
2019-11-06,"Arvinas, Inc. Announces Pricing of Public Offering of Common Stock"
2019-11-06,"Arvinas, Inc. Announces Proposed Offering of Common Stock"
2019-11-05,"Arvinas, Inc. (ARVN) Upgraded to Strong Buy: Here's Why"
2019-11-04,Arvinas Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-10-31,Goldman Sachs: 3 Standout Healthcare Stocks That Could Double
2019-10-30,"Hedge Funds Are Selling Arvinas, Inc. (ARVN)"
2019-10-23,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data"
2019-10-23,"Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders"
2019-10-20,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict"
2019-10-19,"Have Insiders Been Buying Arvinas, Inc. (NASDAQ:ARVN) Shares This Year?"
2019-10-17,Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit
2019-10-02,Arvinas Strengthens Scientific Advisory Board with Leaders in Oncology and Neurological Disorders
2019-10-01,Bayer funnels $55M into new startup with Triangle touchpoint
2019-10-01,"Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio"
2019-09-25,"Wedbush Starts Arvinas At Outperform, Says Lead Assets Could Have Successful Trials"
2019-08-27,"Arvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, an Estrogen Receptor-Targeting PROTAC® Protein Degrader"
2019-08-16,David Swensen Sells DocuSign in 2nd Quarter
2019-08-07,Arvinas To Present at the Wedbush PacGrow Healthcare Conference
2019-08-05,Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update
2019-07-31,Steven Cohen Charges Into Chiasma
2019-07-29,"Arvinas Appoints Ronald Peck, M.D. as Chief Medical Officer"
2019-07-25,Arvinas Strengthens Board of Directors with Addition of Leslie Norwalk
2019-07-18,Arvinas to Present Preclinical Tau-Directed PROTAC® Protein Degrader Data at Alzheimer's Association International Conference
2019-06-27,Will Arvinas Continue to Surge Higher?
2019-06-26,"Is Arvinas, Inc. (ARVN) A Good Stock To Buy?"
2019-06-25,"Arvinas Receives Authorization to Proceed for ARV-471, a PROTAC® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+ / HER2- Breast Cancer"
2019-06-20,Arvinas to Present at the BMO Prescriptions for Success Healthcare Conference
2019-06-06,Arvinas to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
2019-06-04,"Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants"
2019-06-04,Bayer and Arvinas to Collaborate on Human PROTAC® Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC® Applications
2019-05-29,Arvinas Receives Fast Track Designation for its Targeted Protein Degrader ARV-110 as a Treatment for Men with Metastatic Castration-Resistant Prostate Cancer
2019-05-11,"Did Hedge Funds Drop The Ball On Arvinas, Inc. (ARVN) ?"
2019-05-08,Arvinas Reports First Quarter Financial Results and Provides Corporate Update
2019-04-02,"Arvinas Strengthens Management Team with Internal Appointments of Andy Crew, Ph.D. as Chief Technology Officer and Ian Taylor, Ph.D. as Chief Scientific Officer"
2019-03-26,Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
2019-03-25,"Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTAC Protein Degrader, ARV-110"
